A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer

Biological Chemistry

Volumn 394, Issue 3, 2013, Pages 415-420

  Gao, Lin Bo ^a,b   Li, Li Juan ^a   Pan, Xin Min ^a,c   Li, Zhao Hui ^d   Liang, Wei Bo ^a   Bai, Peng ^a   Zhu, Yin Hua ^e   Zhang, Lin ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d Luoyang Central Hospital   (China)

^e PLA Institute of Physical Education   (China)

Author keywords

colorectal cancer; miR 34b c; polymorphism; TP53

Indexed keywords

MICRORNA; MICRORNA 34B; MICRORNA 34C; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER RISK; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84876544385     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0297     Document Type: Article

References (33)

1. Cao, Z., Song, J.H., Park, Y.K., Maeng, E.J., Nam, S.W., Lee, J.Y., and Park, W.S. (2009). The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients. Neoplasma 56, 114-118.
2. Chao, A., Thun, M.J., Connell, C.J., McCullough, M.L., Jacobs, E.J., Flanders, W.D., Rodriguez, C., Sinha, R., and Calle, E.E. (2005). Meat consumption and risk of colorectal cancer. J. Am. Med. Assoc. 293, 172-182.
3. Christoffersen, N.R., Shalgi, R., Frankel, L.B., Leucci, E., Lees, M., Klausen, M., Pilpel, Y., Nielsen, F.C., Oren, M., and Lund, A.H. (2010). p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ. 17, 236-245.
4. Dahabreh, I.J., Linardou, H., Bouzika, P., Varvarigou, V., and Murray, S. (2010). TP53 Arg72Pro polymorphism and colorectal cancer risk: A systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 19, 1840-1847.
5. Dumont, P., Leu, J.I., Della Pietra, A.C., 3rd, George, D.L., and Murphy, M. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33, 357-365.
6. Ferlay, J., Parkin, D.M., and Steliarova-Foucher, E. (2010). Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 46, 765-781.
7. He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007a). A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134.
8. He, L., He, X., Lowe, S.W., and Hannon, G.J. (2007b). microRNAs join the p53 network- another piece in the tumour-suppression puzzle. Nat. Rev. Cancer 7, 819-822.
9. He, X., He, L., and Hannon, G.J. (2007c). The guardian's little helper: MicroRNAs in the p53 tumor suppressor network. Cancer Res. 67, 11099-11101.
10. Hermeking, H. (2010). The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199.
11. Joerger, A.C. and Fersht, A.R. (2008). Structural biology of the tumor suppressor p53. Annu. Rev. Biochem. 77, 557-582.
12. Karim-Kos, H.E., de Vries, E., Soerjomataram, I., Lemmens, V., Siesling, S., and Coebergh, J.W. (2008). Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur. J. Cancer 44, 1345-1389.
13. Kim, N.H., Kim, H.S., Kim, N.G., Lee, I., Choi, H.S., Li, X.Y., Kang, S.E., Cha, S.Y., Ryu, J.K., Na, J.M., et al. (2011). p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci. Signal. 4, ra71.
14. Li, L., Sima, X., Bai, P., Zhang, L., Sun, H., Liang, W., Liu, J., and Gao, L. (2012). Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm. Clin. Dev. Immunol. 2012, 567586.
15. Mojtahedi, Z., Haghshenas, M.R., Hosseini, S.V., Fattahi, M.J., and Ghaderi, A. (2010). p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Indian J. Cancer 47, 31-34.
16. Naccarati, A., Polakova, V., Pardini, B., Vodickova, L., Hemminki, K., Kumar, R., and Vodicka, P. (2012). Mutations and polymorphisms in TP53 gene- an overview on the role in colorectal cancer. Mutagenesis 27, 211-218.
17. Nguyen, S.P., Bent, S., Chen, Y.H., and Terdiman, J.P. (2009). Gender as a risk factor for advanced neoplasia and colorectal cancer: A systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 7, 676-681, e671-673.
18. Park, Y., Hunter, D.J., Spiegelman, D., Bergkvist, L., Berrino, F., van den Brandt, P.A., Buring J.E., Colditz, G.A., Freudenheim, J.L., Fuchs, C.S., et al. (2005). Dietary fiber intake and risk of colorectal cancer: A pooled analysis of prospective cohort studies. J. Am. Med. Assoc. 294, 2849-2857.
19. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108.
20. Soussi, T. and Beroud, C. (2003). Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides. Hum. Mutat. 21, 192-200.
21. Soussi, T. and Wiman, K.G. (2007). Shaping genetic alterations in human cancer: The p53 mutation paradigm. Cancer Cell. 12, 303-312.
22. Soussi, T., Dehouche, K., and Beroud, C. (2000). p53 website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis. Hum. Mutat. 15, 105-113.
23. Tazawa, H., Tsuchiya, N., Izumiya, M., and Nakagama, H. (2007). Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. USA 104, 15472-15477.
24. Tominaga, T., Iwahashi, M., Takifuji, K., Hotta, T., Yokoyama, S., Matsuda, K., Higashiguchi, T., Oku, Y., Nasu, T., and Yamaue, H. (2010). Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer. Int. J. Cancer 126, 1691-1701.
25. Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., and Tokino, T. (2008). Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68, 4123-4132.
26. Vogt, M., Munding, J., Gruner, M., Liffers, S.T., Verdoodt, B., Hauk, J., Steinstraesser, L., Tannapfel, A., and Hermeking, H. (2011). Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch. 458, 313-322.
27. Wang, J.J., Zheng, Y., Sun, L., Wang, L., Yu, P.B., Dong, J.H., Zhang, L., Xu, J., Shi, W., and Ren, Y.C. (2011). TP53 codon 72 polymorphism and colorectal cancer susceptibility: A meta-analysis. Mol. Biol. Rep. 38, 4847-4853.
28. Wei, Y.G., Liu, F., Li, B., Chen, X., Ma, Y., Yan, L.N., Wen, T.F., Xu, M.Q., Wang, W.T., and Yang, J.Y. (2011). Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis. World J. Gastroenterol. 17, 3941-3947.
29. Xu, Y., Liu, L., Liu, J., Zhang, Y., Zhu, J., Chen, J., Liu, S., Liu, Z., Shi, H., Shen, H., et al. (2011). A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int. J. Cancer 128, 412-417.
30. Yamakuchi, M., Ferlito, M., and Lowenstein, C.J. (2008). miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. USA 105, 13421-13426.
31. Yang, L., Parkin, D.M., Ferlay, J., Li, L., and Chen, Y. (2005). Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol. Biomarkers. Prev. 14, 243-250.
32. Yang, L., Belaguli, N., and Berger, D.H. (2009). MicroRNA and colorectal cancer. World J. Surg. 33, 638-646.
33. Zhang, Y.M., Zhou, X.C., Xu, Z., and Tang, C.J. (2012). Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk. Genet. Mol. Res. 11, 3389-3397.